Equities

MANI Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

MANI Inc

Actions
  • Price (USD)12.82
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta1.0222
Data delayed at least 15 minutes, as of Sep 18 2024.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

MANI Inc is a Japan-based company mainly engaged in the manufacture and sale of surgical related products, eyeless needle related products, and dental related products. It operates through three business segments. The Surgical Related Products segment provides surgical equipment, including skin sutures, ophthalmic knives, deep sutures, bone saws, vascular knives, ophthalmic trocars, and vitreous forceps. The Eyeless Needle Related Products segment provides surgical needle-attached sutures, eyeless suture needles (materials for surgical needle-attached sutures), and eyed suture needles (surgical suture needles). The Dental Related Products segment provides dental root canal treatment equipment, including reamers, files, nickel titanium (NiTi) files, cleansers, and broaches, dental rotary cutting equipment, including diamond burrs, carbide burrs, stainless steel burrs, and peeso reamers, and dental materials, including dental restorative materials.

  • Revenue in JPY (TTM)30.14bn
  • Net income in JPY4.94bn
  • Incorporated1959
  • Employees4.14k
  • Location
    MANI Inc8-3, Kiyohara Industrial ParkUTSUNOMIYA-SHI 321-3231JapanJPN
  • Phone+81 286671811
  • Fax+81 286671700
  • Websitehttps://www.mani.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.